Suppression of the C/EBP family of transcription factors in adipose tissue causes lipodystrophy

Journal of Molecular Endocrinology

Volumn 46, Issue 3, 2011, Pages 175-192

  Chatterjee, Raghunath ^a   Bhattacharya, Paramita ^a   Gavrilova, Oksana ^b   Glass, Kimberly ^c   Moitra, Jaideep ^a,f   Myakishev, Max ^a   Pack, Stephanie ^b   Jou, William ^b   Feigenbaum, Lionel ^d   Eckhaus, Michael ^e   Vinson, Charles ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c Bldg 142   (United States)

^d SAIC FREDERICK INC   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CCAAT ENHANCER BINDING PROTEIN ALPHA; FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; FATTY ACID SYNTHESIS; FATTY LIVER; FEMALE; FIBROBLAST; GENE EXPRESSION; GENETIC ANALYSIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HISTOPATHOLOGY; HOMEOSTASIS; HYPERINSULINEMIA; HYPERLIPIDEMIA; INFLAMMATION; INSULIN RESISTANCE; LIPODYSTROPHY; MALE; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; SUBCUTANEOUS FAT; TISSUE CULTURE; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; BLOTTING, WESTERN; BODY COMPOSITION; CALORIMETRY, INDIRECT; CCAAT-ENHANCER-BINDING PROTEINS; CELLS, CULTURED; EATING; FATTY ACID-BINDING PROTEINS; FIBROBLASTS; LIPODYSTROPHY; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROTEINS; TRIGLYCERIDES;

EID: 79959529886     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-10-0172     Document Type: Article

References (76)

1. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, Minnemann T, Shulman GI & Kahn BB 2001 Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409 729-733. (doi:10.1038/35055575)
2. Agarwal AK & Garg A 2002 A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy. Journal of Clinical Endocrinology and Metabolism 87 408-411. (doi:10.1210/jc.87.1.408)
3. Agarwal AK, Arioglu E, De Almeida S, Akkoc N, Taylor SI, Bowcock AM, Barnes RI & Garg A 2002 AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nature Genetics 31 21-23. (doi:10.1038/ng880)
4. Agarwal AK, Fryns JP, Auchus RJ & Garg A 2003 Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Human Molecular Genetics 12 1995-2001. (doi:10.1093/hmg/ddg213)
5. Ahn S, Olive M, Aggarwal S, Krylov D, Ginty DD & Vinson C 1998 A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos. Molecular and Cellular Biology 18 967-977.
6. Bernlohr DA, Doering TL, Kelly TJ Jr & Lane MD 1985 Tissue specific expression of p422 protein, a putative lipid carrier, in mouse adipocytes. Biochemical and Biophysical Research Communications 132 850-855. (doi:10.1016/0006-291X(85)91209-4)
7. Burant CF, Sreenan S, Hirano K, Tai TA, Lohmiller J, Lukens J, Davidson NO, Ross S & Graves RA 1997 Troglitazone action is independent of adipose tissue. Journal of Clinical Investigation 100 2900-2908. (doi:10.1172/JCI119839)
8. Colombo C, Haluzik M, Cutson JJ, Dietz KR, Marcus-Samuels B, Vinson C, Gavrilova O & Reitman ML 2003 Opposite effects of background genotype on muscle and liver insulin sensitivity of lipoatrophic mice. Role of triglyceride clearance. Journal of Biological Chemistry 278 3992-3999. (doi:10.1074/jbc.M207665200)
9. Combs TP, Berg AH, Rajala MW, Klebanov S, Iyengar P, Jimenez-Chillaron JC, Patti ME, Klein SL, Weinstein RS & Scherer PE 2003 Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52 268-276. (doi:10.2337/diabetes.52.2.268)
10. Ebihara K, Kusakabe T, Masuzaki H, Kobayashi N, Tanaka T, Chusho H, Miyanaga F, Miyazawa T, Hayashi T, Hosoda K et al. 2004 Gene and phenotype analysis of congenital generalized lipodystrophy in Japanese: a novel homozygous nonsense mutation in seipin gene. Journal of Clinical Endocrinology and Metabolism 89 2360-2364. (doi:10.1210/jc.2003-031211)
11. El-Jack AK, Hamm JK, Pilch PF & Farmer SR 1999 Reconstitution of insulin-sensitive glucose transport in fibroblasts requires expression of both PPARgamma and C/EBPalpha. Journal of Biological Chemistry 274 7946-7951. (doi:10.1074/jbc.274.12.7946)
12. Fiorenza CG, Chou SH & Mantzoros CS 2011 Lipodystrophy: pathophysiology and advances in treatment. Nature Reviews Endocrinology 7 137-150. (doi:10.1038/nrendo.2010.199)
13. Garg A & Misra A 2004 Lipodystrophies: rare disorders causing metabolic syndrome. Endocrinology and Metabolism Clinics of North America 33 305-331. (doi:10.1016/j.ecl.2004.03.003)
14. Gavrilova O, Marcus-Samuels B, Graham D, Kim JK, Shulman GI, Castle AL, Vinson C, Eckhaus M & Reitman ML 2000a Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. Journal of Clinical Investigation 105 271-278. (doi:10.1172/ JCI7901)
15. Gavrilova O, Marcus-Samuels B & Reitman ML 2000b Lack of responses to a beta3-adrenergic agonist in lipoatrophic A-ZIP/F-1 mice. Diabetes 49 1910-1916. (doi:10.2337/diabetes.49.11.1910)
16. Gavrilova O, Haluzik M, Matsusue K, Cutson JJ, Johnson L, Dietz KR, Nicol CJ, Vinson C, Gonzalez FJ & Reitman ML 2003 Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. Journal of Biological Chemistry 278 34268-34276. (doi:10.1074/ jbc.M300043200)
17. George S, Rochford JJ, Wolfrum C, Gray SL, Schinner S, Wilson JC, Soos MA, Murgatroyd PR, Williams RM, Acerini CL et al. 2004 A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304 1325-1328. (doi:10.1126/science.1096706)
18. Gougeon ML, Penicaud L, Fromenty B, Leclercq P, Viard JP & Capeau J 2004 Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations. Antiviral Therapy 9 161-177.
19. Gustafson B, Jack MM, Cushman SW & Smith U 2003 Adiponectin gene activation by thiazolidinediones requires PPAR gamma 2, but not C/EBP alpha-evidence for differential regulation of the aP2 and adiponectin genes. Biochemical and Biophysical Research Communications 308 933-939. (doi:10.1016/S0006-291X(03)01518-3)
20. Hartman HB, Hu X, Tyler KX, Dalal CK & Lazar MA 2002 Mechanisms regulating adipocyte expression of resistin. Journal of Biological Chemistry 277 19754-19761. (doi:10.1074/jbc.M201451200)
21. Hayashi YK, Matsuda C, Ogawa M, Goto K, Tominaga K, Mitsuhashi S, Park YE, Nonaka I, Hino-Fukuyo N, Haginoya K et al. 2009 Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. Journal of Clinical Investigation 119 2623-2633. (doi:10.1172/ JCI38660)
22. Herrera R, Ro HS, Robinson GS, Xanthopoulos KG & Spiegelman BM 1989 A direct role for C/EBP and the AP-I-binding site in gene expression linked to adipocyte differentiation. Molecular and Cellular Biology 9 5331-5339.
23. Himms-Hagen J, Cui J, Danforth E Jr, Taatjes DJ, Lang SS, Waters BL & Claus TH 1994 Effect of CL-316,243, a thermogenic beta 3-agonist, on energy balance and brown and white adipose tissues in rats. American Journal of Physiology 266 R1371-R1382.
24. Hollenberg AN, Susulic VS, Madura JP, Zhang B, Moller DE, Tontonoz P, Sarraf P, Spiegelman BM & Lowell BB 1997 Functional antagonism between CCAAT/Enhancer binding protein-alpha and peroxisome proliferator-activated receptor-gamma on the leptin promoter. Journal of Biological Chemistry 272 5283-5290. (doi:10. 1074/jbc.272.8.5283)
25. Huang-Doran I, Sleigh A, Rochford JJ, O'Rahilly S & Savage DB 2010 Lipodystrophy: metabolic insights from a rare disorder. Journal of Endocrinology 207 245-255. (doi:10.1677/JOE-10-0272)
26. Kadowaki T & Yamauchi T 2005 Adiponectin and adiponectin receptors. Endocrine Reviews 26 439-451. (doi:10.1210/er.2005-0005)
27. Karagiannides I, Tchkonia T, Dobson DE, Steppan CM, Cummins P, Chan G, Salvatori K, Hadzopoulou-Cladaras M & Kirkland JL 2001 Altered expression of C/EBP family members results in decreased adipogenesis with aging. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 280 R1772-R1780.
28. Kershaw EE & Flier JS 2004 Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism 89 2548-2556. (doi:10.1210/jc.2004-0395)
29. Kim JK, Wi JK & Youn JH 1996 Plasma free fatty acids decrease insulinstimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats. Diabetes 45 446-453. (doi:10.2337/diabetes.45.4.446)
30. Kim CA, Delepine M, Boutet E, El Mourabit H, Le Lay S, Meier M, Nemani M, Bridel E, Leite CC, Bertola DR et al. 2008 Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. Journal of Clinical Endocrinology and Metabolism 93 1129-1134. (doi:10.1210/jc.2007-1328)
31. Koopman P, Ashworth A & Lovell-Badge R 1991 The ZFY gene family in humans and mice. Trends in Genetics 7 132-136. (doi:10.1016/ 0168-9525(91)90458-3)
32. Kopelman PG 2000 Obesity as a medical problem. Nature 404 635-643. (doi:10.1038/35007508)
33. Koutkia P & Grinspoon S 2004 HIV-associated lipodystrophy: pathogenesis, prognosis, treatment, and controversies. Annual Review of Medicine 55 303-317. (doi:10.1146/annurev.med.55. 091902.104412)
34. Krylov D, Olive M & Vinson C 1995 Extending dimerization interfaces: the bZIP basic region can form a coiled coil. EMBO Journal 14 5329-5337.
35. Laustsen PG, Michael MD, Crute BE, Cohen SE, Ueki K, Kulkarni RN, Keller SR, Lienhard GE & Kahn CR 2002 Lipoatrophic diabetes in Irs1(K/K)/Irs3(K/K) double knockout mice. Genes and Development 16 3213-3222. (doi:10.1101/gad.1034802)
36. Lichti U, Anders J & Yuspa SH 2008 Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice. Nature Protocols 3 799-810. (doi:10.1038/nprot.2008.50)
37. Linhart HG, Ishimura-Oka K, DeMayo F, Kibe T, Repka D, Poindexter B, Bick RJ & Darlington GJ 2001 C/EBPalpha is required for differentiation of white, but not brown, adipose tissue. PNAS 98 12532-12537. (doi:10.1073/pnas.211416898)
38. Magre J, Delepine M, Khallouf E, Gedde-Dahl T Jr, Van Maldergem L, Sobel E, Papp J, Meier M, Megarbane A, Bachy A et al. 2001 Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nature Genetics 28 365-370. (doi:10.1038/ng585)
39. Mandrup S & Lane MD 1997 Regulating adipogenesis. Journal of Biological Chemistry 272 5367-5370. (doi:10.1074/jbc.272.9.5367)
40. Mason MM, He Y, Chen H, Quon MJ & Reitman M 1998 Regulation of leptin promoter function by Sp1, C/EBP, and a novel factor. Endocrinology 139 1013-1022. (doi:10.1210/en.139.3.1013)
41. Miller SG, De Vos P, Guerre-Millo M, Wong K, Hermann T, Staels B, Briggs MR & Auwerx J 1996 The adipocyte specific transcription factor C/EBPalpha modulates human ob gene expression. PNAS 93 5507-5511. (doi:10.1073/pnas.93.11.5507)
42. Moitra J, Mason MM, Olive M, Krylov D, Gavrilova O, Marcus-Samuels B, Feigenbaum L, Lee E, Aoyama T, Eckhaus M et al. 1998 Life without white fat: a transgenic mouse. Genes and Development 12 3168-3181. (doi:10.1101/gad.12.20.3168)
43. Morrison RF & Farmer SR 2000 Hormonal signaling and transcriptional control of adipocyte differentiation. Journal of Nutrition 130 3116S-3121S.
44. Nicholls DG & Locke RM 1984 Thermogenic mechanisms in brown fat. Physiological Reviews 64 1-64.
45. Olive M, Krylov D, Echlin DR, Gardner K, Taparowsky E & Vinson C 1997 A dominant negative to activation protein-1 (AP1) that abolishes DNA binding and inhibits oncogenesis. Journal of Biological Chemistry 272 18586-18594. (doi:10.1074/jbc.272.30. 18586)
46. Pajvani UB, Trujillo ME, Combs TP, Iyengar P, Jelicks L, Roth KA, Kitsis RN & Scherer PE 2005 Fat apoptosis through targeted activation of caspase 8: a newmousemodel of inducible and reversible lipoatrophy. Nature Medicine 11 797-803. (doi:10.1038/nm1262)
47. Park BH, Qiang L & Farmer SR 2004 Phosphorylation of C/EBPbeta at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes. Molecular and Cellular Biology 24 8671-8680. (doi:10. 1128/MCB.24.19.8671-8680.2004)
48. Peterfy M, Phan J, Xu P & Reue K 2001 Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nature Genetics 27 121-124. (doi:10.1038/83685)
49. Qi C, Surapureddi S, Zhu YJ, Yu S, Kashireddy P, Rao MS & Reddy JK 2003 Transcriptional coactivator PRIP, the peroxisome proliferatoractivated receptor gamma (PPARgamma)-interacting protein, is required for PPARgamma-mediated adipogenesis. Journal of Biological Chemistry 278 25281-25284. (doi:10.1074/jbc.C300175200)
50. Reitman ML 2004 Magic bullets melt fat. Nature Medicine 10 581-582. (doi:10.1038/nm0604-581)
51. Reitman ML, Arioglu E, Gavrilova O & Taylor SI 2000 Lipoatrophy revisited. Trends in Endocrinology and Metabolism 11 410-416. (doi:10. 1016/S1043-2760(00)00309-X)
52. Rishi V, Bhattacharya P, Chatterjee R, Rozenberg J, Zhao J, Glass K, Fitzgerald P & Vinson C 2010 Cp Gmethylation of half-CRE sequences creates C/EBPalpha binding sites that activate some tissue-specific genes. PNAS 107 20311-20316. (doi:10.1073/pnas.1008688107)
53. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM &Mortensen RM 1999 PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Molecular Cell 4 611-617. (doi:10.1016/S1097-2765(00)80211-7)
54. Rosen ED, Walkey CJ, Puigserver P & Spiegelman BM 2000 Transcriptional regulation of adipogenesis. Genes and Development 14 1293-1307. (doi:10.1101/gad.14.11.1293)
55. Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, Gonzalez FJ & Spiegelman BM 2002 C/EBPPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes and Development 16 22-26. (doi:10.1101/gad.948702)
56. Ross SR, Graves RA & Spiegelman BM 1993 Targeted expression of a toxin gene to adipose tissue: transgenic mice resistant to obesity. Genes and Development 7 1318-1324. (doi:10.1101/gad.7.7b.1318)
57. Rubio-Cabezas O, Puri V, Murano I, Saudek V, Semple RK, Dash S, Hyden CS, Bottomley W, Vigouroux C, Magre J et al. 2009 Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Molecular Medicine 1 280-287. (doi:10.1002/emmm.200900037)
58. Saito K, Tobe T, Yoda M, Nakano Y, Choi-Miura NH & Tomita M 1999 Regulation of gelatin-binding protein 28 (GBP28) gene expression by C/EBP. Biological and Pharmaceutical Bulletin 22 1158-1162.
59. Savage DB, Tan GD, Acerini CL, Jebb SA, Agostini M, Gurnell M, Williams RL, Umpleby AM, Thomas EL, Bell JD et al. 2003 Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptorgamma. Diabetes 52 910-917. (doi:10.2337/diabetes.52.4.910)
60. Schaffler A & Scholmerich J 2010 Innate immunity and adipose tissue biology. Trends in Immunology 31 228-235. (doi:10.1016/j.it. 2010.03.001)
61. Seo JB, Noh MJ, Yoo EJ, Park SY, Park J, Lee IK, Park SD & Kim JB 2003 Functional characterization of the human resistin promoter with adipocyte determination-and differentiation-dependent factor 1/sterol regulatory element binding protein 1c and CCAAT enhancer binding protein-alpha. Molecular Endocrinology 17 1522-1533. (doi:10.1210/me.2003-0028)
62. Shimomura I, Hammer RE, Richardson JA, Ikemoto S, Bashmakov Y, Goldstein JL & Brown MS 1998 Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes and Development 12 3182-3194. (doi:10.1101/gad.12.20.3182)
63. Stephens JM, Butts MD & Pekala PH 1992 Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumour necrosis factor-alpha. Journal of Molecular Endocrinology 9 61-72. (doi:10.1677/jme.0.0090061)
64. Steppan CM & Lazar MA 2004 The current biology of resistin. Journal of Internal Medicine 255 439-447. (doi:10.1111/j.1365-2796. 2004.01306.x)
65. Taketo M, Schroeder AC, Mobraaten LE, Gunning KB, Hanten G, Fox RR, Roderick TH, Stewart CL, Lilly F, Hansen CT et al. 1991 FVB/N: an inbred mouse strain preferable for transgenic analyses. PNAS 88 2065-2069. (doi:10.1073/pnas.88.6.2065)
66. Tan K, Kimber WA, Luan J, Soos MA, Semple RK, Wareham NJ, O'Rahilly S & Barroso I 2007 Analysis of genetic variation in Akt2/PKB-beta in severe insulin resistance, lipodystrophy, type 2 diabetes, and related metabolic phenotypes. Diabetes 56 714-719. (doi:10.2337/db06-0921)
67. Tanaka T, Yoshida N, Kishimoto T & Akira S 1997 Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO Journal 16 7432-7443. (doi:10.1093/emboj/ 16.24.7432)
68. Vinson CR, Hai T & Boyd SM 1993 Dimerization specificity of the leucine zipper-containing bZIP motif on DNA binding: prediction and rational design. Genes and Development 7 1047-1058. (doi:10. 1101/gad.7.6.1047)
69. Vinson C, Myakishev M, Acharya A, Mir AA, Moll JR & Bonovich M 2002 Classification of human B-ZIP proteins based on dimerization properties. Molecular and Cellular Biology 22 6321-6335. (doi:10. 1128/MCB.22.18.6321-6335.2002)
70. Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsayed SV, Wilde MD, Taylor LR, Wilson DR & Darlington GJ 1995 Impaired energy homeostasis in C/EBP alpha knockout mice. Science 269 1108-1112. (doi:10.1126/science.7652557)
71. Wertheim N, Cai Z & McGraw TE 2004 The transcription factor CCAAT/enhancer-binding protein alpha is required for the intracellular retention of GLUT4. Journal of Biological Chemistry 279 41468-41476. (doi:10.1074/jbc.M405088200)
72. Wu Z, Rosen ED, Brun R, Hauser S, Adelmant G, Troy AE, McKeon C, Darlington GJ & Spiegelman BM 1999 Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Molecular Cell 3 151-158. (doi:10.1016/S1097-2765(00)80306-8)
73. Yamamoto H, Kurebayashi S, Hirose T, Kouhara H & Kasayama S 2002 Reduced IRS-2 and GLUT4 expression in PPARgamma2-induced adipocytes derived from C/EBPbeta and C/EBPdelta-deficient mouse embryonic fibroblasts. Journal of Cell Science 115 3601-3607. (doi:10.1242/jcs.00044)
74. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N et al. 2001 The fatderived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine 7 941-946. (doi:10.1038/90984)
75. Yao-Borengasser A, Rassouli N, Varma V, Bodles AM, Rasouli N, Unal R, Phanavanh B, Ranganathan G, McGehee RE Jr & Kern PA 2008 Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferatoractivated receptor-gamma responsiveness. Journal of Clinical Endocrinology and Metabolism 93 4431-4439. (doi:10.1210/jc.2008-0782)
76. Zhang JW, Tang QQ, Vinson C & Lane MD 2004 Dominant-negative C/EBP disruptsmitotic clonal expansion and differentiation of 3T3-L1 preadipocytes. PNAS 101 43-47. (doi:10.1073/pnas.0307229101)